If so, it provides mechanistic insights into the prognostic utility of MR in tamoxifen-treated breast cancers [14] and the potential for MR and RARβ to influence breast cancer cell growth through altered energy metabolism. The gene discussed is RARB; the disease is breast carcinoma.